Idera Pharmaceuticals, Inc. Bouncing on Phase 2 Success
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
IDRA
7:16 am Idera Pharma announces positive top-line data in Phase 2 trial of IMO-8400; trial meets primary objective of demonstrating safety and tolerability over 12-week treatment period; IMO-8400 also demonstrates clinical proof-of-concept i
moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to view […]
Idera to Present at the Cowen & Co. 34th Annual Health Care Conference
[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that Company man moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to […]
Idera to Present at the 2014 RBC Capital Markets’ Global Healthcare Conference
[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that Company man moreView todays social media effects on IDRAView the latest stocks trending across Twitter. Click to view dashboardSee who Idera is hiring next, click here to […]
